Liang Xue
Director Pfizer
Liang Xue has a strong background in scientific research, with a focus on protein studies and drug discovery. He began his career as an at the University of Science and Technology of China in 2004, where he gained valuable experience in the field. In 2008, he transitioned to a Graduate Research Assistant position at Purdue University. Following his time at Purdue, Liang Xue joined the Howard Hughes Medical Institute | California Institute of Technology as a Postdoctoral Fellow, specializing in proteomics and high throughput drug discovery. Currently, Liang Xue is director of bioinformatics at Pfizer, responsible for leading research and contributing to scientific advancements.
Seminars
Thursday 5th February 2026
Standardizing Proteomics Data Analysis & Selecting Appropriate Analysis Frameworks to Ensure Reproducibility & Statistical Accuracy
2:00 pm
- Creating robust and reproducible data analysis methodologies to facilitate precise biomedical conclusions
- Developing consistent statistical and data normalization strategies to mitigate for missing data and variability across proteomics platforms
- Harmonizing assay design and sample prep to ensure compatibility with downstream analysis methods across in vitro, in vivo, and clinical models
